Teleflex Inc

TFX

Equity

ISIN US8793691069 / Valor 976212

New York Stock Exchange, Inc (2025-04-04)

USD 131.93-4.39%

Teleflex Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Teleflex Inc is a global company specializing in medical technologies aimed at enhancing the health and well-being of individuals. With a diverse portfolio of solutions in areas such as vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine, and respiratory care, Teleflex focuses on purpose-driven innovation to address unmet clinical needs and improve patient outcomes. With over 14,000 employees worldwide, the company is committed to making a difference in the healthcare industry through its innovative products and services.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

Teleflex Inc reported a GAAP revenue of $764.4 million for the third quarter of 2024, marking a 2.4% increase compared to the same period in the previous year. On a constant currency basis, the revenue growth was 2.2%.

Earnings Per Share

For the third quarter of 2024, Teleflex Inc's GAAP diluted earnings per share (EPS) from continuing operations was $2.36, down from $2.91 in the prior year period. The adjusted diluted EPS from continuing operations was $3.49, compared to $3.64 in the previous year.

Segment Performance

Teleflex Inc's Interventional and Vascular Access segments showed strong performances, with Interventional revenue growing by 11.8% and Vascular Access by 6.5% in the third quarter of 2024. These gains helped offset unexpected softness in OEM revenues.

2024 Outlook

Teleflex Inc has adjusted its full-year 2024 revenue growth outlook, lowering the GAAP revenue growth guidance range to 2.90% to 3.40%. However, the company raised the low end of its adjusted diluted EPS from continuing operations guidance range to $13.90 to $14.20.

Share Repurchase Program

In the third quarter of 2024, Teleflex Inc authorized a $500 million share repurchase program, which includes a $200 million accelerated share repurchase. This move is part of the company's strategy to augment its disciplined capital allocation.

Summarized from source with an LLMView Source

Key figures

-37.7%1Y

-61.7%3Y

-55.2%5Y

Performance

29.6%1Y

31.2%3Y

34.0%5Y

Volatility